| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.005 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.005 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |